Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (71-80 of 451) with videos related to

Pageof 46
Sort By:
The Oncologist|August 7, 2013
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitorsDaniel J Lenihan, Peter R Kowey
Journal of the American College of Cardiology|August 29, 2015
Observing the ObviousPeter R Kowey, Victoria M Robinson
Circulation|March 11, 2024
Antiarrhythmic Drug Therapy: Where Do We Go From Here?Peter R Kowey, Gerald V Naccarelli
JACC. Clinical Electrophysiology|May 29, 2024
Class IC Drugs in Cardiomyopathy: Keeping an Open MindPeter R Kowey, Farah M Olleik
Heart, Lung & Circulation|August 6, 2017
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017Logan Kanagaratnam, Peter Kowey, David Whalley
Circulation|May 12, 2020
The Relentless Pursuit of New Drugs to Treat Cardiac ArrhythmiasPeter R Kowey, Victoria M Robinson
Journal of Thoracic Disease|February 26, 2015
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?Colleen M Hanley, Peter R Kowey
The American Journal of Cardiology|May 20, 2014
Peter Russell Kowey, MD: a conversation with the editorPeter Russell Kowey, William Clifford Roberts
Clinical Cardiology|July 30, 2013
Oral anticoagulants to reduce the risk of stroke in atrial fibrillation: how should a clinician choose?Ilyas Mohammed, Wajihuddin Syed, Peter R Kowey
Cardiology Clinics|March 31, 2019
Atrial Fibrillation Ablation Should Be First-Line Therapy in Heart Failure Patients: CONAmanulla Khaji, Colleen Hanley, Peter R Kowey
Pageof 46

Showing results (71-80 of 451) with videos related to

Sort By:
Pageof 46
The Oncologist|August 7, 2013
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitorsDaniel J Lenihan, Peter R Kowey
Journal of the American College of Cardiology|August 29, 2015
Observing the ObviousPeter R Kowey, Victoria M Robinson
Circulation|March 11, 2024
Antiarrhythmic Drug Therapy: Where Do We Go From Here?Peter R Kowey, Gerald V Naccarelli
JACC. Clinical Electrophysiology|May 29, 2024
Class IC Drugs in Cardiomyopathy: Keeping an Open MindPeter R Kowey, Farah M Olleik
Heart, Lung & Circulation|August 6, 2017
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017Logan Kanagaratnam, Peter Kowey, David Whalley
Circulation|May 12, 2020
The Relentless Pursuit of New Drugs to Treat Cardiac ArrhythmiasPeter R Kowey, Victoria M Robinson
Journal of Thoracic Disease|February 26, 2015
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?Colleen M Hanley, Peter R Kowey
The American Journal of Cardiology|May 20, 2014
Peter Russell Kowey, MD: a conversation with the editorPeter Russell Kowey, William Clifford Roberts
Clinical Cardiology|July 30, 2013
Oral anticoagulants to reduce the risk of stroke in atrial fibrillation: how should a clinician choose?Ilyas Mohammed, Wajihuddin Syed, Peter R Kowey
Cardiology Clinics|March 31, 2019
Atrial Fibrillation Ablation Should Be First-Line Therapy in Heart Failure Patients: CONAmanulla Khaji, Colleen Hanley, Peter R Kowey
Pageof 46